GNH USA

Europe — EMA

Migard (Frovatriptan)

GNH USA supplies Migard (Frovatriptan), a Triptan (5‑HT1B/1D receptor agonist) for acute treatment of migraine attacks. Request a quote for global supply.

Frovatriptan

Request sourcing

1
Pack/s

What is Frovatriptan?

Frovatriptan, the active ingredient in Migard, is a Triptan (5‑HT1B/1D receptor agonist) presented as an oral tablet for oral use. It provides acute treatment of migraine attacks in adults.\n\nGNH India supplies Migard as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Frovatriptan used for?

Frovatriptan is a selective serotonin receptor agonist used in the acute management of migraine and related disorders.\n\nMigraine attacks: provides rapid relief of headache, nausea, and photophobia associated with an acute migraine episode.\nAcute migraine with aura: aborts migraine attacks that are preceded by visual or sensory aura symptoms.\nMenstrual migraine: reduces the frequency and severity of migraine episodes linked to the menstrual cycle.

What are the side effects of Frovatriptan?

Frovatriptan may cause a range of adverse reactions, most of which are mild and transient.\n\nCommon Side Effects:\n- Nausea\n- Dizziness\n- Fatigue\n- Dry mouth\n- Somnolence\n- Chest discomfort\n\nSerious or Rare Side Effects:\n- Coronary vasospasm or myocardial infarction\n- Severe hypertension\n- Serotonin syndrome, especially when combined with serotonergic agents\n- Allergic reactions such as rash or angioedema

What precautions apply to Frovatriptan?

Use of Frovatriptan requires careful assessment of cardiovascular and other health factors.\n\nContraindicated in cardiovascular disease: avoid in patients with coronary artery disease, uncontrolled hypertension, or history of stroke.\nAvoid in pregnancy: safety not established; use only if potential benefit justifies risk.\nCaution in hepatic impairment: dose adjustment may be needed in moderate to severe liver disease.\nBreastfeeding considerations: limited data; weigh benefits against potential infant exposure.\nDrug‑specific warnings: monitor for signs of serotonin syndrome when used with other serotonergic drugs.\nStore at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

What does Frovatriptan interact with?

Frovatriptan can interact with several medication classes, influencing safety and efficacy.\n\nMajor Interactions (Avoid):\n- MAO inhibitors: risk of severe hypertension and serotonin syndrome.\n- SSRIs, SNRIs, or other serotonergic agents: increased potential for serotonin syndrome.\n- Ergotamine or other triptans: additive vasoconstrictive effects may precipitate cardiovascular events.\n\nModerate Interactions (Monitor Closely):\n- Beta‑blockers: may enhance hypotensive effects.\n- CYP3A4 inhibitors (e.g., ketoconazole): may increase plasma concentrations of Frovatriptan.

Frequently asked questions

What is Migard used for?+
Migard contains the active ingredient Frovatriptan and is prescribed for the acute treatment of migraine attacks, including episodes with or without aura and menstrual‑related migraine. It works to relieve headache, nausea, and sensitivity to light or sound when taken at the onset of a migraine.
How does Frovatriptan work?+
Frovatriptan is a selective agonist of serotonin 5‑HT1B and 5‑HT1D receptors. By stimulating these receptors, it causes constriction of dilated cranial blood vessels and blocks the release of pain‑triggering neuropeptides from trigeminal nerves, thereby reducing migraine pain and associated symptoms.
What is the usual dose of Migard?+
The prescribed dose of Migard is determined by the treating physician based on the individual’s clinical condition, age, and response to therapy. Patients should follow the prescriber’s instructions and not exceed the recommended amount without medical advice.
Is Migard safe during pregnancy or breastfeeding?+
Safety of Frovatriptan in pregnancy has not been established, and it is generally avoided unless the potential benefit outweighs the risk. Limited data are available for breastfeeding; therefore, use should be discussed with a healthcare professional to assess possible infant exposure.
How do I order Migard from GNH USA?+
To request Migard, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.
How does Migard compare with other migraine treatments?+
Migard (Frovatriptan) belongs to the triptan class, which is generally more effective for moderate to severe migraine than non‑specific analgesics such as NSAIDs. Compared with other triptans, Frovatriptan has a longer half‑life, offering sustained relief but may have a slower onset of action.
What are the storage requirements for Migard?+
Migard should be stored at ambient temperature, preferably below 25 °C. Keep the tablets in the original blister pack or container, protect them from moisture, heat, and direct sunlight to maintain stability and potency throughout the shelf life.
How is Migard administered?+
Migard is taken orally, usually as a single tablet at the first sign of a migraine attack. The tablet should be swallowed whole with water and not crushed or chewed. If the migraine recurs, a second dose may be taken after a minimum interval as advised by the prescriber.
What are the most serious risks associated with Migard?+
Serious risks include coronary vasospasm, myocardial infarction, severe hypertension, and serotonin syndrome, especially when combined with other serotonergic drugs. Patients experiencing chest pain, severe headache, or signs of serotonin excess should seek immediate medical attention.
Who should not use Migard?+
Migard is contraindicated in patients with known cardiovascular disease, uncontrolled hypertension, a history of stroke or transient ischemic attack, severe hepatic impairment, and those taking MAO inhibitors or other triptans. Individuals with known hypersensitivity to Frovatriptan or any excipients should also avoid its use.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Frovatriptan
Route
Oral Use
Manufacturer
Menarini International Operations Luxembourg S.A.
Origin
EU

Related products

Allegro

Allegro

Frovatriptan

Berlin-Chemie Ag
EU
Auradol

Auradol

Frovatriptan

Istituto Luso Farmaco D'italia S.P.A.
EU
Dorlise

Dorlise

Frovatriptan

Menarini International Operations Luxembourg S.A.
EU
Eumitan

Eumitan

Frovatriptan

Menarini International Operations Luxembourg S.A.
EU